Questcor Must Face Infantile Spasm Drug Antitrust Suit
A California federal judge on Friday refused to toss an antitrust suit by Retrophin Inc. accusing Questcor Pharmaceuticals Inc. of illegally monopolizing certain medical treatment areas through its acquisition and exclusive...To view the full article, register now.
Already a subscriber? Click here to view full article